Pharmaceutical

Trimtech closes seed fund round to advance CNS therapeutics pipeline

Trimtech Therapeutics has closed a seed funding round of $31m (£25m) to advance its pipeline of CNS penetrant therapeutics.

Mar 7, 2025 - 06:00
Trimtech closes seed fund round to advance CNS therapeutics pipeline
Trimtech Therapeutics has closed a seed funding round of $31m (£25m) to advance its pipeline of CNS penetrant therapeutics.
Read the original article

Tags:

Previous Article

Novo Nordisk cuts Wegovy price through new direct-to-patient online pharmacy

Next Article

BioNTech’s Malaria Vaccine Trial Temporarily Suspended by FDA

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

GSK’s lung cancer therapy gains EMA PRIME designation

GSK’s lung cancer therapy gains EMA PRIME designation

Dec 17, 2024

Chronic kidney disease raises risk of sudden cardiac arrest among Hispanics and Latinos

Chronic kidney disease raises risk of sudden cardiac ar...

Oct 12, 2023

STAT+: Biogen’s boardroom scandal saddles CEO with first crisis

STAT+: Biogen’s boardroom scandal saddles CEO with firs...

Jun 14, 2023